News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
167 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39672)
2015 (44432)
2016 (38329)
2017 (37188)
2018 (39119)
2019 (51334)
2020 (57662)
2021 (58720)
2022 (53927)
2023 (42564)
2024 (37441)
2025 (33090)
2026 (24384)
Month
January (2882)
February (2030)
March (1769)
April (2200)
May (2664)
June (3161)
July (3087)
August (3800)
September (4259)
October (5135)
November (4629)
December (3503)
Day
1 (168)
2 (76)
4 (3)
5 (150)
6 (144)
7 (139)
8 (146)
9 (72)
10 (4)
11 (1)
12 (157)
13 (167)
14 (125)
15 (111)
16 (54)
17 (4)
19 (20)
20 (49)
21 (57)
22 (62)
23 (38)
25 (1)
26 (79)
27 (106)
28 (97)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
1
2
4
5
6
7
8
9
10
11
12
13
14
15
16
17
19
20
21
22
23
25
26
27
28
Drug Development
Actinium Announces Submission of IND For Actimab-A in Combination With CLAG-M for Patients with Relapsed or Refractory AML
The planned Phase 1 trial studying Actimab-A in combination with CLAG-M will be an investigator initiated trial conducted at the Medical College of Wisconsin in a Phase 1, dose escalation study.
February 13, 2018
·
7 min read
Okayama University Research: Cell Membrane as Material for Bone Formation
In a first study, the researchers observed that chondrocytes burst near the mineralized area, which they suggest might be a space-making mechanism for mineral expansion.
February 13, 2018
·
5 min read
Drug Development
Reata Announces Improvements in Kidney Function With Bardoxolone Methyl Maintained for Two Years in PAH Patients From LARIAT Trial
The two-year duration of sustained eGFR improvement in LARIAT is twice as long as Reata has previously reported for bardoxolone.
February 13, 2018
·
8 min read
Business
Supernus to Host Fourth Quarter and Full Year 2017 Earnings Conference Call
The Company expects to report the financial results for the fourth quarter and full year of 2017 after 5:00 PM ET on Tuesday, February 27, 2018.
February 13, 2018
·
1 min read
Business
Dova Pharmaceuticals to Announce Fourth Quarter and Full Year 2017 Financial Results on February 15, 2018
To participate on the live call, please dial 866-550-8145 (domestic) or +1-430-775-1344 (international) and provide the conference ID 7796295 five to 10 minutes before the start of the call.
February 13, 2018
·
1 min read
Affimed Announces Proposed Public Offering of Common Stock
All of the shares in the offering will be sold by Affimed.
February 13, 2018
·
3 min read
Business
Fulgent Genetics to Announce Fourth Quarter and Full Year 2017 Financial Results on February 28, 2018
The call can be accessed through a live audio webcast in the Investors section of the company’s website.
February 13, 2018
·
1 min read
Business
BioSig Technologies to Open Operations Center in Austin, Texas
The new offices will complement the Company’s headquarters in Los Angeles, CA and will become an operational hub hosting administration, field engineering and sales.
February 13, 2018
·
3 min read
Business
Nu-Med Plus Announces Keith L. Merrell as Their Full-Time CFO and Secretary/Treasurer
Mr. Merrell brings over 30 years of business and accounting experience while serving as Chief Financial Officer or Controller of five companies both public and private.
February 13, 2018
·
2 min read
Business
Foamix Pharmaceuticals Fourth Quarter and Fiscal Year 2017 Financial Results Conference Call & Webcast Scheduled for February 28
Foamix will host a conference call and webcast at 8:30am Eastern Time on Wednesday, February 28.
February 13, 2018
·
1 min read
Previous
12 of 17
Next